MMP9 and medulloblastoma: Conversely, pharmacological targeting of β-adrenergic functions abrogates MMP9 secretion in medulloblastoma cells (Annabi et al., 2010) suggesting a potential cross-talk between β-adrenergic receptors and MMP9 (Rietz and Spiers, 2012).